153 related articles for article (PubMed ID: 9415063)
1. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
Jörns A; Munday R; Tiedge M; Lenzen S
J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
[TBL] [Abstract][Full Text] [Related]
2. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
[TBL] [Abstract][Full Text] [Related]
3. Relation between triketone structure, generation of reactive oxygen species, and selective toxicity of the diabetogenic agent alloxan.
Elsner M; Gurgul-Convey E; Lenzen S
Antioxid Redox Signal; 2008 Apr; 10(4):691-9. PubMed ID: 18177230
[TBL] [Abstract][Full Text] [Related]
4. Rubidium uptake by mouse pancreatic islets exposed to 6-hydroxydopamine, ninhydrin, or other generators of hydroxyl radicals.
Grankvist K; Sehlin J; Täljedal IB
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):175-81. PubMed ID: 3087136
[TBL] [Abstract][Full Text] [Related]
5. Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
Lenzen S; Freytag S; Panten U; Flatt PR; Bailey CJ
Pharmacol Toxicol; 1990 Mar; 66(3):157-62. PubMed ID: 2185463
[TBL] [Abstract][Full Text] [Related]
6. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan.
Tyrberg B; Andersson A; Borg LA
Gen Comp Endocrinol; 2001 Jun; 122(3):238-51. PubMed ID: 11356036
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
Zhang HN; He JH; Yuan L; Lin ZB
Life Sci; 2003 Sep; 73(18):2307-19. PubMed ID: 12941433
[TBL] [Abstract][Full Text] [Related]
8. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro.
Jörns A; Tiedge M; Lenzen S; Munday R
Free Radic Biol Med; 1999 May; 26(9-10):1300-4. PubMed ID: 10381203
[TBL] [Abstract][Full Text] [Related]
9. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin.
Lenzen S; Munday R
Biochem Pharmacol; 1991 Sep; 42(7):1385-91. PubMed ID: 1930261
[TBL] [Abstract][Full Text] [Related]
10. Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity.
Tyrberg B; Eizirik DL; Marklund SL; Olejnicka B; Madsen OD; Andersson A
Pharmacol Toxicol; 1999 Dec; 85(6):269-75. PubMed ID: 10628902
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives.
Munday R; Ludwig K; Lenzen S
J Endocrinol; 1993 Oct; 139(1):153-63. PubMed ID: 8254288
[TBL] [Abstract][Full Text] [Related]
12. Interactions of diabetogenic compounds: cyproheptadine and alloxan.
Chatterjee AK; Varayotha V; Fischer LJ
Fundam Appl Toxicol; 1991 Jan; 16(1):188-97. PubMed ID: 2019344
[TBL] [Abstract][Full Text] [Related]
13. Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic B-cell against alloxan.
Malaisse-Lagae F; Sener A; Malaisse WJ
Biochim Biophys Acta; 1983 Feb; 762(1):36-43. PubMed ID: 6338936
[TBL] [Abstract][Full Text] [Related]
14. Protective role of superoxide dismutase against diabetogenic drugs.
Gandy SE; Buse MG; Crouch RK
J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
[TBL] [Abstract][Full Text] [Related]
15. Protection of B cells against the effect of alloxan.
Abdel-Rahman MS; Elrakhawy FI; Iskander FA
Toxicol Lett; 1992 Nov; 63(2):155-64. PubMed ID: 1455447
[TBL] [Abstract][Full Text] [Related]
16. Effects of alloxan and ninhydrin on mitochondrial Ca2+ transport.
Lenzen S; Brünig H; Münster W
Mol Cell Biochem; 1992 Dec; 118(2):141-51. PubMed ID: 1293509
[TBL] [Abstract][Full Text] [Related]
17. Effects of alloxan on the islets of Langerhans: inhibition of leucine metabolism and insulin secretion.
Borg LA
Biochim Biophys Acta; 1981 Oct; 677(2):257-62. PubMed ID: 7028133
[TBL] [Abstract][Full Text] [Related]
18. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
Eizirik DL; Pipeleers DG; Ling Z; Welsh N; Hellerström C; Andersson A
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9253-6. PubMed ID: 7937750
[TBL] [Abstract][Full Text] [Related]
19. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.
Grankvist K; Marklund S; Sehlin J; Täljedal IB
Biochem J; 1979 Jul; 182(1):17-25. PubMed ID: 40548
[TBL] [Abstract][Full Text] [Related]
20. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
Thaete LG; Crouch RK; Buse MG; Spicer SS
Diabetologia; 1985 Sep; 28(9):677-82. PubMed ID: 3905479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
